Cardiovas Diabetol
Zepbound (tirzepatide) activates GLP-1 and GIP receptors in the hypothalamus, the brain region controlling body temperature regulation
This study builds on Ro's strong foundation of clinical research, including eight abstracts that the company presented at ObesityWeek 2025 in November, spanning topics from the use of AI to improve the patient experience, such as an evaluation of Ro's LLM-enabled adverse event reporting tool, to outcomes among patients treated with GLP-1s, such as those with osteoarthritis
Our results show that chronic treatment with sCT, liraglutide, a combination of sCT and liraglutide or a stepwise administration of the aforementioned compounds did not affect the regulation of pre-proglucagon (PPG), GLP-1R, calcitonin receptor (CTR), Receptor Activity Modifying Protein (RAMP)1, RAMP2 or RAMP3 mRNA compared to vehicle (Fig
" Medical weight loss treatment " isn't just a buzzword